lovastatin has been researched along with Thyroid Carcinoma, Anaplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TC; Shui, HA; Wang, CY | 1 |
| Chin, LH; Fan, YC; Horng, S; Hsu, SP; Tang, LW; Tsai, YC; Tseng, JH; Zhong, WB | 1 |
| Chin, LH; Hsu, SP; Liang, YC; Zhong, WB | 1 |
| Cho, S; Choi, HJ; Choi, JY; Chung, YS; Jee, HG; Lee, KE; Oh, SK; Ryou, HJ; Suh, YJ; Yoon, K; Youn, YK | 1 |
4 other study(ies) available for lovastatin and Thyroid Carcinoma, Anaplastic
| Article | Year |
|---|---|
Dual effects for lovastatin in anaplastic thyroid cancer: the pivotal effect of transketolase (TKT) on lovastatin and tumor proliferation.
Topics: Animals; Apoptosis; Body Weight; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Lovastatin; Male; Mice, Nude; Oxythiamine; Proteomics; Thyroid Carcinoma, Anaplastic; Transketolase; Tumor Burden | 2018 |
A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Checkpoints; Cell Line, Tumor; Chromans; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Drug Synergism; Humans; Lipid Metabolism; Lovastatin; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Thiazolidinediones; Thyroid Carcinoma, Anaplastic; Troglitazone; Xenograft Model Antitumor Assays | 2018 |
Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
Topics: Cell Line, Tumor; Cell Movement; Chromans; Cyclic AMP Response Element-Binding Protein; Cysteine-Rich Protein 61; Down-Regulation; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Humans; Lovastatin; Signal Transduction; Thiazolidinediones; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Troglitazone | 2015 |
Is there a treatment advantage when paclitaxel and lovastatin are combined to dose anaplastic thyroid carcinoma cell lines?
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Humans; Lovastatin; Paclitaxel; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2011 |